tofacitinibbaricitinibTOFBAR
…e Janus kinase inhibitors (JAKi), such as baricitinib (BAR) and tofacitinib (TOF), are oral therapeutic options for rheumatoid arthritis (R…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 7,621–7,680 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
angiotensin II1angiotensin II inhibitors1angiotensin II receptor blocker1angiotensin converting enzyme (ACE) inhibitor1angiotensin converting enzyme inhibitors-angiotensin II receptor blockers1anifrolumabAbstract1anlotinib-induced1antacid1anthelmintic medication1anthelmintics1anti PD-11anti-4-1BB1anti-B7-H3 antibody‒drug conjugate1anti-BAFF1anti-CD38 mAb1anti-CD38 monoclonal antibodies1anti-CD401anti-CD40 agonist antibody1anti-CD47 monoclonal antibody1anti-CGRP monoclonal antibodies1anti-CTLA-4 antibody1anti-CTLA-4 mAb1anti-CTLA4 antibody1anti-HER2 antibody-drug conjugates1anti-Ly6G1anti-MDA5 antibody1anti-Mullerian Hormone1anti-Müllerian hormone1anti-OA pharmacological agents1anti-OX401anti-PD-(L)1-based1anti-PD-1 ICB1anti-PD-L1 avelumab1anti-Parkinson’s drugs1anti-Sjögren’s syndrome antigen A1anti-TIM-31anti-Th/To-positive1anti-VEGF agents1anti-VEGFR21anti-anginal medication1anti-cancer compounds1anti-cytotoxic T lymphocyte-associated antigen-4 immune checkpoint inhibitors1anti-diabetic agents1anti-fibrotic medications1anti-histamines1anti-hypertensive drugs1anti-infectious agents1anti-inflammatory drugs1anti-inflammatory reliever1anti-interferon1anti-oestrogen medications1anti-pan γδ x CD1231anti-pan γδ x CD123 bispecific antibody1anti-programmed cell death protein 11anti-programmed cell death protein 1 (PD1)1anti-programmed cell death protein-1/programmed death-ligand 11anti-programmed death (ligand) 11anti-programmed death-ligand 1 (PD-(L)1)1anti-programmed death-ligand 1 (PD-L1)1anti-programmed death-ligand 1 antibodies1
Articles mentioning drugs
10,506 articles · page 12 of 876fosfomycin trometamolvancomycinamoxicillinlinezolidamoxicillin-clavulanatedaptomycinteicoplaninfluoroquinolonescarbapenems
…inolones. For UTIs, 18.65%, 18.18% and 25.68% were treated with fosfomycin trometamol; 16.08%, 13.42% and 11.67% with fluoroquinolones; and 4.82%, 6.…
95.9%
BDP/FF/GB pMDIBUD/FF/GB pMDIFLU/VIL/UMEC DPI
…meter (MMAD) were compared across all active components.Results BDP/FF/GB pMDI demonstrated substantially greater eFPF vs either BUD/FF/GB pMD…
rituximabhydroxychloroquineprednisoloneazathioprineaspirinmycophenolate mofetilmethotrexate
… high-dose corticosteroids, six sessions of plasmapheresis, and rituximab. Due to persistent pancytopenia with febrile neutropenia, empir…
MercaptopurineCarvedilolMycophenolateOmeprazoleBudesonideLamivudineBulevirtideAzathioprineLansoprazoleTacrolimus+8 more
…Immunosuppression 100 (27%)• Azathioprine (38)• Budesonide (7)• Mercaptopurine (5)• Mycophenolate (40)• Prednisolone (4)• Tacrolimus (6) Prima…
nivolumabipilimumab
…ously evaluated in patients with advanced melanoma treated with nivolumab plus ipilimumab. This analysis compared TFS for nivolumab plus …
infliximabadalimumabVedolizumabazathioprineQuantiFERONlevofloxacinrifampicinpyridoxine
…iagnosed with Crohn’s disease at age 10. Initially treated with infliximab, he was switched to adalimumab due to allergic reaction. He did…
ThiopurineAzathioprine
…in Pharmacol. 2024;90:3296–307.Ooi CY, Bohane TD, Lee D, et al. Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.…
FIT-positiveFITFIT-negative
…more negative lower GI investigations in FIT-negative patients (FIT-positive 102 (47.7%), FIT-negative 59 (27.6%)). CRC was diagnosed in 1.4…
midazolamMorphineoctreotidedinoprostoneClonidinedopaminenoradrenalinefurosemideglucagonatracurium+1 more
…isible particles, and degradation products.Conclusion Morphine, midazolam, noradrenaline, dopamine, and clonidine are strong candidates f…
baricitinibabrocitinibdupilumablebrikizumabtralokinumabupadacitinib
…numab 300 mg biweekly; and -44.15% (95% CI -50.44 to -37.86) vs baricitinib 2 mg diary. Statistically significant differences were found be…
ranibizumabafliberceptfaricimabBrolucizumab
…tients (10 injections); faricimab 94 patients (321 injections); ranibizumab 37 patients (127 injections).Classified by most frequent diagno…